Orphan drugs

Results: 558



#Item
411st line treatment: what has changed in the last 2 years? 10th European International Kidney Cancer Symposium Lyon April 2015

1st line treatment: what has changed in the last 2 years? 10th European International Kidney Cancer Symposium Lyon April 2015

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:49
42Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor

Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor

Add to Reading List

Source URL: www.biopredict.com

Language: English - Date: 2006-11-28 17:36:48
43Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final

Microsoft Word - Apjohn Ventures Fund 2Q10 Letter Final

Add to Reading List

Source URL: www.apjohnventures.com

Language: English
44Sergio Bracarda MD Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy

Sergio Bracarda MD Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 14:06:16
45Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Sylvie NEGRIER MD, PhD Centre Léon Bérard, Lyon Université Lyon I

Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Sylvie NEGRIER MD, PhD Centre Léon Bérard, Lyon Université Lyon I

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:42
46What Have Sequencing Trials Taught Us? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy

What Have Sequencing Trials Taught Us? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:45
47Award ID: CC121004 Project Title: Biobetter Cancer Monoclonal Antibody Program Award Mechanism: Company Commercialization

Award ID: CC121004 Project Title: Biobetter Cancer Monoclonal Antibody Program Award Mechanism: Company Commercialization

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2015-03-24 12:30:05
48Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:25:25
49Have Results of Recent Randomized Trials Changed the Role of mTOR Inhibitors? Bernard Escudier Institut Gustave Roussy

Have Results of Recent Randomized Trials Changed the Role of mTOR Inhibitors? Bernard Escudier Institut Gustave Roussy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:46
50Treatment beyond second line Camillo Porta Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy

Treatment beyond second line Camillo Porta Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:46